In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.

This week on “Uncanny Valley,” we go behind the scenes of our Nathan Fielder cover story, unpack tech billionaires’ generous promises, and discuss the suspicious letters sent to US election offices.

It’s the latest in a growing wave of bets that AI companies are making on brain data.

OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.

The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models don't yet have the data to properly decode it.